{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T15:28:06Z","timestamp":1789918086870,"version":"4.0.1"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T00:00:00Z","timestamp":1548115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.03162","type":"journal-article","created":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T10:26:16Z","timestamp":1548152776000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Antigen Production After Latency Reversal and Expression of Inhibitory Receptors in CD8+ T Cells Limit the Killing of HIV-1 Reactivated Cells"],"prefix":"10.3389","volume":"9","author":[{"given":"Alba","family":"Ruiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Blanch-Lombarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Jimenez-Moyano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Ouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Mothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Galvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meritxell","family":"Genesc\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Martinez-Picado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Goulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Barnard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie","family":"Howell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonaventura","family":"Clotet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia G.","family":"Prado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,1,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/S0140-6736(13)61809-7","article-title":"The end of AIDS: HIV infection as a chronic disease","volume":"382","author":"Deeks","year":"2013","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/nm1295-1284","article-title":"In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency","volume":"1","author":"Chun","year":"1995","journal-title":"Nat Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1126\/science.1254194","article-title":"Specific HIV integration sites are linked to clonal expansion and persistence of infected cells","volume":"345","author":"Maldarelli","year":"2014","journal-title":"Science"},{"key":"B4","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/nm.1972","article-title":"HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation","volume":"15","author":"Chomont","year":"2009","journal-title":"Nat Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e1005142","DOI":"10.1371\/journal.ppat.1005142","article-title":"The Depsipeptide romidepsin reverses HIV-1 latency in vivo","volume":"11","author":"S\u00f8gaard","year":"2015","journal-title":"PLoS Pathog."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e463","DOI":"10.1016\/S2352-3018(16)30055-8","article-title":"Combined effect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B\/2A trial","volume":"3","author":"Leth","year":"2016","journal-title":"Lancet HIV"},{"key":"B7","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/nature11286","article-title":"Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy","volume":"487","author":"Archin","year":"2012","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.2174\/1568026615666150901114138","article-title":"Therapeutic approaches to eradicate latent HIV-1 in resting CD4+ T Cells","volume":"16","author":"Sluis-Cremer","year":"2016","journal-title":"Curr Top Med Chem."},{"key":"B9","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.cell.2013.09.020","article-title":"Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure","volume":"155","author":"Ho","year":"2013","journal-title":"Cell"},{"key":"B10","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1084\/jem.20170193","article-title":"Proliferation of latently infected CD4 + T cells carrying replication-competent HIV-1: potential role in latent reservoir dynamics","volume":"214","author":"Hosmane","year":"2017","journal-title":"J Exp Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.immuni.2012.01.014","article-title":"Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation","volume":"36","author":"Shan","year":"2012","journal-title":"Immunity"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1093\/cid\/cis188","article-title":"Immune responses driven by protective human leukocyte antigen alleles from long-term nonprogressors are associated with low HIV reservoir in central memory CD4 T cells","volume":"54","author":"Descours","year":"2012","journal-title":"Clin Infect Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e1001300","DOI":"10.1371\/journal.ppat.1001300","article-title":"Elite suppressors harbor low levels of integrated HIV DNA and high levels of 2-LTR circular HIV DNA compared to HIV+ patients On and Off HAART","volume":"7","author":"Graf","year":"2011","journal-title":"PLoS Pathog."},{"key":"B14","doi-asserted-by":"publisher","first-page":"6148","DOI":"10.1128\/JVI.00419-16","article-title":"Long-term spontaneous control of HIV-1 is related to low frequency of infected cells and inefficient viral reactivation","volume":"90","author":"Noel","year":"2016","journal-title":"J Virol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nm1520","article-title":"CD8+ T-cell responses to different HIV proteins have discordant associations with viral load","volume":"13","author":"Kiepiela","year":"2007","journal-title":"Nat Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"6776","DOI":"10.1073\/pnas.0611244104","article-title":"HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype","volume":"104","author":"S\u00e1ez-Ciri\u00f3n","year":"2007","journal-title":"Proc Natl Acad Sci USA."},{"key":"B17","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.immuni.2016.08.018","article-title":"CD8 + Lymphocytes are required for maintaining viral suppression in SIV-infected macaques treated with short-term antiretroviral therapy","volume":"45","author":"Cartwright","year":"2016","journal-title":"Immunity"},{"key":"B18","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.4049\/jimmunol.162.3.1780","article-title":"Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART)","volume":"162","author":"Gray","year":"1999","journal-title":"J Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"6508","DOI":"10.1128\/JVI.75.14.6508-6516.2001","article-title":"Decay kinetics of human immunodeficiency virus-specific CD8+ T cells in peripheral blood after initiation of highly active antiretroviral therapy","volume":"75","author":"Casazza","year":"2001","journal-title":"J Virol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nature14053","article-title":"Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations","volume":"517","author":"Deng","year":"2015","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.chom.2017.03.008","article-title":"Defective HIV-1 proviruses are expressed and can be recognized by cytotoxic T lymphocytes, which shape the proviral landscape","volume":"21","author":"Pollack","year":"2017","journal-title":"Cell Host Microbe."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e1004287","DOI":"10.1371\/journal.ppat.1004287","article-title":"Histone deacetylase inhibitors impair the elimination of HIV-infected cells by cytotoxic T-lymphocytes","volume":"10","author":"Jones","year":"2014","journal-title":"PLoS Pathog."},{"key":"B23","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ebiom.2016.04.019","article-title":"The effect of latency reversal agents on primary CD8+ T cells: implications for shock and kill strategies for human immunodeficiency virus eradication","volume":"8","author":"Walker-Sperling","year":"2016","journal-title":"EBioMedicine"},{"key":"B24","doi-asserted-by":"publisher","first-page":"30749","DOI":"10.1038\/srep30749","article-title":"The differential short- and long-term effects of HIV-1 latency-reversing agents on T cell function","volume":"6","author":"Clutton","year":"2016","journal-title":"Sci Rep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1097\/COH.0000000000000088","article-title":"Coinhibitory receptors and CD8 T cell exhaustion in chronic infections","volume":"9","author":"Kuchroo","year":"2014","journal-title":"Curr Opin HIV AIDS"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.3389\/fimmu.2017.01215","article-title":"Coinhibitory receptor expression and immune checkpoint blockade: maintaining a balance in CD8+ T cell responses to chronic viral infections and cancer","volume":"8","author":"Okoye","year":"2017","journal-title":"Front Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1038\/nm1482","article-title":"Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction","volume":"12","author":"Trautmann","year":"2006","journal-title":"Nat Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"4805","DOI":"10.1182\/blood-2010-11-317297","article-title":"Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infection","volume":"117","author":"Yamamoto","year":"2011","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature05115","article-title":"PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression","volume":"443","author":"Day","year":"2006","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/ni.1679","article-title":"Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection","volume":"10","author":"Blackburn","year":"2009","journal-title":"Nat Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1128\/JVI.02131-12","article-title":"Early antigen presentation of protective HIV-1 KF11Gag and KK10 gag epitopes from incoming viral particles facilitates rapid recognition of infected cells by specific CD8+ T cells","volume":"87","author":"Kloverpris","year":"2013","journal-title":"J Virol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nprot.2009.227","article-title":"Synchronous infection of SIV and HIV in vitro for virology, immunology and vaccine-related studies","volume":"5","author":"Sacha","year":"2010","journal-title":"Nat Protoc."},{"key":"B33","doi-asserted-by":"publisher","first-page":"38329","DOI":"10.1038\/srep38329","article-title":"Protein expression from unintegrated HIV-1 DNA introduces bias in primary in vitro post-integration latency models","volume":"6","author":"Bonczkowski","year":"2016","journal-title":"Sci Rep."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1172\/JCI80142","article-title":"ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations","volume":"125","author":"Laird","year":"2015","journal-title":"J Clin Invest."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1016\/S2352-3018(14)70014-1","article-title":"Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1\/2, single group, clinical trial","volume":"1","author":"Rasmussen","year":"2014","journal-title":"Lancet HIV"},{"key":"B36","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00280-014-2612-8","article-title":"A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and varying degrees of renal function","volume":"75","author":"Sharma","year":"2015","journal-title":"Cancer Chemother Pharmacol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e1004071","DOI":"10.1371\/journal.ppat.1004071","article-title":"Histone deacetylase inhibitor romidepsin induces HIV expression in CD4 T cells from patients on suppressive antiretroviral therapy at concentrations achieved by clinical dosing","volume":"10","author":"Wei","year":"2014","journal-title":"PLoS Pathog."},{"key":"B38","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jviromet.2006.04.004","article-title":"Use of a novel assay based on intact recombinant viruses expressing green (EGFP) or red (DsRed2) fluorescent proteins to examine the contribution of pol and env genes to overall HIV-1 replicative fitness","volume":"136","author":"Weber","year":"2006","journal-title":"J Virol Methods"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1128\/JVI.01882-08","article-title":"Functional consequences of human immunodeficiency virus escape from an HLA-B*13-restricted CD8+ T-cell epitope in p1 Gag protein","volume":"83","author":"Prado","year":"2009","journal-title":"J Virol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e1005545","DOI":"10.1371\/journal.ppat.1005545","article-title":"A subset of latency-reversing agents expose HIV-infected resting CD4+ T-cells to recognition by cytotoxic T-lymphocytes","volume":"12","author":"Jones","year":"2016","journal-title":"PLoS Pathog."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1038\/mt.2016.114","article-title":"Elimination of latently HIV-infected cells from antiretroviral therapy-suppressed subjects by engineered immune-mobilizing T-cell receptors","volume":"24","author":"Yang","year":"2016","journal-title":"Mol Ther."},{"key":"B42","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/COH.0000000000000124","article-title":"Preserving HIV-specific T cell responses: does timing of antiretroviral therapy help?","volume":"10","author":"Macatangay","year":"2015","journal-title":"Curr Opin HIV AIDS"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e1005177","DOI":"10.1371\/journal.ppat.1005177","article-title":"CD39 Expression identifies terminally exhausted CD8+ T cells","volume":"11","author":"Gupta","year":"2015","journal-title":"PLoS Pathog."},{"key":"B44","doi-asserted-by":"publisher","first-page":"6959","DOI":"10.1128\/JVI.00531-12","article-title":"Elite Controllers with low to absent effector CD8+ T cell responses maintain highly functional, broadly directed central memory responses","volume":"86","author":"Ndhlovu","year":"2012","journal-title":"J Virol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"10134","DOI":"10.1128\/JVI.00647-14","article-title":"Predicting the impact of CD8+ T cell polyfunctionality on HIV disease progression","volume":"88","author":"Graw","year":"2014","journal-title":"J Virol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ebiom.2017.07.019","article-title":"Vorinostat renders the replication-competent latent reservoir of human immunodeficiency virus (HIV) vulnerable to clearance by CD8 T cells","volume":"23","author":"Sung","year":"2017","journal-title":"EBioMedicine"},{"key":"B47","doi-asserted-by":"publisher","first-page":"4973","DOI":"10.1128\/JVI.02362-06","article-title":"Epitope-dependent avidity thresholds for cytotoxic T-lymphocyte clearance of virus-infected cells","volume":"81","author":"Bennett","year":"2007","journal-title":"J Virol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"eaag2285","DOI":"10.1126\/scitranslmed.aag2285","article-title":"Follicular CD8 T cells accumulate in HIV infection and can kill infected cells in vitro via bispecific antibodies","volume":"9","author":"Petrovas","year":"2017","journal-title":"Sci Transl Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40425-018-0316-z","article-title":"Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations","volume":"6","author":"Gong","year":"2018","journal-title":"J Immunother Cancer"},{"key":"B50","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nri.2017.112","article-title":"Immune checkpoint blockade in infectious diseases","volume":"18","author":"Wykes","year":"2017","journal-title":"Nat Rev Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.jtho.2018.03.031","article-title":"Safety and efficacy of PD-1 inhibitors among HIV-positive patients with non-small cell lung cancer","volume":"13","author":"Ostios-Garcia","year":"2018","journal-title":"J Thorac Oncol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1093\/infdis\/jix191","article-title":"Clinical trial of the anti-PD-L1 antibody BMS-936559 in HIV-1 infected participants on suppressive antiretroviral therapy","volume":"215","author":"Gay","year":"2017","journal-title":"J Infect Dis."},{"key":"B53","doi-asserted-by":"publisher","first-page":"10543","DOI":"10.1128\/JVI.00793-10","article-title":"Efficacious early antiviral activity of hiv gag- and pol-specific HLA-B*2705-restricted CD8+ T cells","volume":"84","author":"Payne","year":"2010","journal-title":"J Virol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1093\/cid\/civ456","article-title":"Establishment and replenishment of the viral reservoir in perinatally HIV-1-infected children initiating very early antiretroviral therapy","volume":"61","author":"Mart\u00ednez-Bonet","year":"2015","journal-title":"Clin Infect Dis."},{"key":"B55","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/cyto.a.21015","article-title":"SPICE: exploration and analysis of post-cytometric complex multivariate datasets","volume":"79","author":"Roederer","year":"2011","journal-title":"Cytometry A"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.03162\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T02:58:00Z","timestamp":1694573880000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.03162\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,22]]},"references-count":55,"alternative-id":["10.3389\/fimmu.2018.03162"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.03162","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,22]]},"article-number":"3162"}}